A scientific experiment to study the attenuation of intubation response with dexmeditomedine nebulization & sublingual nitroglycerin spray
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/12/060709
- Lead Sponsor
- Department of Anesthesiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age group 18 - 60 years
Both genders
ASA grade I and II
Exclusion Criteria
Patient refusal
Pregnancy
Emergency surgery
Patient with anticipated difficult airway
Modified mallampatti III and IV
Laryngoscope and intubation time >20s
Obese patients with BMI >30kg/m2
H/o chronic hepatic renal or cardiac disease
H/o drug allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Attenuation of intubation response with dexmeditomedine nebulization versus sublingual nitroglycerin sprayTimepoint: Baseline <br/ ><br>At induction <br/ ><br>1 min after induction <br/ ><br>2 min after induction <br/ ><br>3 min after induction <br/ ><br>At intubation <br/ ><br>1 min after intubation <br/ ><br>2 min after intubation <br/ ><br>3 min after intubation <br/ ><br>5 min after intubation <br/ ><br>10 min after intubation <br/ ><br>15 min after intubation <br/ ><br>30 min after intubation <br/ ><br>At extubation <br/ ><br>5 min after extubation <br/ ><br>10 min after extubation <br/ ><br>15 min after extubation <br/ ><br>20 min after extubation <br/ ><br>25 min after extubation <br/ ><br>30 min after extubation
- Secondary Outcome Measures
Name Time Method Adverse effects of dexmeditomedine and nitroglycerinTimepoint: 24 hours